Loss of pirenzepine regional selectivity following solubilitization and partial purification of the putative M₁ and M₂ muscarinic receptor subtypesBAUMGOLD, J; MERRIL, C; GERSHON, E. S et al.Brain research. 1987, Vol 2, Num 1, pp 7-14, issn 0006-8993Article

M₁ muscarinic acetylcholine receptor agonism alters sleep without affecting memory consolidationNISSEN, Christoph; POWER, Ann E; NOFZINGER, Eric A et al.Journal of cognitive neuroscience. 2006, Vol 18, Num 11, pp 1799-1807, issn 0898-929X, 9 p.Article

Affinities of muscarinic drugs for [³H]N-methylscopolamine (NMS) and [³H]oxotremorine (OXO) binding to a mixture of M₁-M₄ muscarinic receptors : use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classesSHARIF, N. A; WILLIAMS, G. W; DESANTIS, L. M et al.Neurochemical research. 1995, Vol 20, Num 6, pp 669-674, issn 0364-3190Article

Blockade of spatial learning by the M₁ muscarinic antagonist pirenzepineHAGAN, J. J; JANSEN, J. H. M; BROEKKAMP, C. L. E et al.Psychopharmacologia. 1987, Vol 93, Num 4, pp 470-476, issn 0033-3158Article

Structural correlates for down-regulation of m1 and m2 muscarinic receptor subtypesMALATYNSKA, E; WAITE, S; WEI, H.-B et al.Brain research bulletin. 1998, Vol 47, Num 3, pp 285-290, issn 0361-9230Article

Binding-site modeling of the muscarinic m1 receptor : a combination of homology-based and indirect approachesNORDVALL, G; HACKSELL, U.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 8, pp 967-976, issn 0022-2623Article

Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM₁ muscarinic acetylcholine receptorMELANCON, Bruce J; GOGLIOTTI, Rocco D; MORRISON, Ryan D et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 10, pp 3467-3472, issn 0960-894X, 6 p.Article

Development of novel M₁ antagonist scaffolds through the continued optimization of the MLPCN probe ML012MELANCON, Bruce J; UTLEY, Thomas J; JEFFREY CONN, P et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 15, pp 5035-5040, issn 0960-894X, 6 p.Article

Long-term wash-resistant effects of brief interaction of xanomeline at the M₁ muscarinic receptorDE LORME, Kayla C; SIKORSKI, Krista L; GRANT, Marianne K. O et al.Neuroscience letters. 2006, Vol 410, Num 1, pp 11-14, issn 0304-3940, 4 p.Article

No antidepressant effect of biperiden compared with placebo in depression : a double-bind 6-week clinical trialGILLIN, J. C; LAURIELLO, J; KELSOE, J. R et al.Psychiatry research. 1995, Vol 58, Num 2, pp 99-105, issn 0165-1781Article

Conformational analysis and receptor modelling of m1 and m2 selective antagonistsKERCKHOFF, H; HÖLTJE, H.-D.Pharmazie. 1994, Vol 49, Num 8, pp 566-573, issn 0031-7144Article

The effects of biperiden on nap sleep after sleep derprivation in depressed patientsDRESSING, H; RIEMANN, D; GANN, H et al.Neuropsychopharmacology (New York, NY). 1992, Vol 7, Num 1, pp 1-5, issn 0893-133XArticle

Growth factor-like effects mediated by muscarinic receptors in PC12M1PINKAS-KRAMARSKI, R; STEIN, R; LINDENBOIM, L et al.Journal of neurochemistry. 1992, Vol 59, Num 6, pp 2158-2166, issn 0022-3042Article

Stereoselectivity of proclidine binding to muscarinic receptor subtypes M₁, M₂ and M₄WAELBROECK, M; CAMUS, J; TASTENOY, M et al.European journal of pharmacology. 1990, Vol 189, Num 2-3, pp 135-142, issn 0014-2999, 8 p.Article

Differential selectivity of M1 and M3 type muscarinic acetylcholine receptors in coupling with a G protein Go1α examined in Xenopus oocytesFUJII, K; KASAHARA, J; NAKAMURA, K et al.Neuroscience letters. 1996, Vol 215, Num 2, pp 131-133, issn 0304-3940Article

Therapeutic strategies in Alzheimer's disease based on M1 agonists : A reviewFISHER, A.L' Année gérontologique (Ed. française). 1996, pp 110-119, issn 0990-2295, NSArticle

Exocrine pancreatic secretion in man following one week of 1-muscarinic receptor blockadeMALFERTHEINER, P; NELSON, D. K; KEMMER, T. P et al.Alimentary pharmacology & therapeutics. 1993, Vol 7, Num 4, pp 423-428, issn 0269-2813Article

Premedication with non-selective and M₁-selective muscarinic antagonists before ECTLEVINE, J; SWARTZ, M; FEIBEL, H et al.Israel journal of psychiatry and related sciences. 1993, Vol 30, Num 3, pp 179-182, issn 0333-7308Article

Effect of a M₁-selective muscarinic receptor antagonist (Pirenzepine) on basal bronchomotor tone in young womenFUJIMURA, M; KAMIO, Y; MATSUDA, T et al.Respiration (Basel). 1992, Vol 59, Num 2, pp 102-106, issn 0025-7931Article

Age-dependent decrease in the affinity of muscarinic M1 receptors in neocortex of rhesus monkeysGUILIANA VANNUCCHI, M; GOLDMAN-RAKIC, P. S.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 24, pp 11475-11479, issn 0027-8424Article

Pharmacological basis for functional selectivity of partial muscarinic receptor agonistsHELDMAN, E; BARG, J; FISHER, A et al.European journal of pharmacology. 1996, Vol 297, Num 3, pp 283-291, issn 0014-2999Article

Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptorsPOTTER, L. T; FERRENDELLI, C. A; HANCHETT, H. E et al.Molecular pharmacology. 1989, Vol 35, Num 5, pp 652-660, issn 0026-895XArticle

Respiratory responses to pirenzepine in healthy subjectsCAZZOLA, M; RUSSO, S; DE SANTIS, D et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1987, Vol 25, Num 2, pp 105-109, issn 0174-4879Article

Synthesis and biological characterization of a series of novel diaryl amide M₁ antagonistsPOSLUSNEY, Michael S; SEVEL, Christian; LINDSLEY, Craig W et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 22, pp 6923-6928, issn 0960-894X, 6 p.Article

Doctor, necesito un antídoto para su antídoto. Un caso de síndrome anticolinérgico por biperideno = Doctor, I need an antidote for your antidote. A case biperidene induced anticholinergic syndromeCARABANO AGUADO, I; PELAYO BAEZA, F; SANCHEZ-PUELLES, J. González-Valcárcel et al.Anales de pediatria (2003. Ed. impresa). 2010, Vol 72, Num 5, pp 368-369, issn 1695-4033, 2 p.Article